Global Fecal Immunochemical Diagnostic Tests Supply, Demand and Key Producers, 2026-2032
The global Fecal Immunochemical Diagnostic Tests market size is expected to reach $ 2260 million by 2032, rising at a market growth of 9.0% CAGR during the forecast period (2026-2032).
Fecal immunochemical diagnostic testing is a non-invasive diagnostic method based on the principle of antigen antibody specific reaction, which screens for lower gastrointestinal bleeding by detecting trace amounts of human hemoglobin in fecal samples. This test uses specific antibodies against human hemoglobin, which can accurately identify and measure the hemoglobin content in feces. The results are usually reported quantitatively or qualitatively in micrograms (? g/g) per gram of feces. Compared to traditional guaiacol based fecal occult blood testing, fecal immunochemical diagnostic testing has significant advantages: it does not require dietary restrictions (avoiding red meat or certain vegetables) or discontinuation of medication (such as vitamin C), as it specifically targets human hemoglobin and avoids peroxidase interference in food, thereby significantly reducing false positive rates. The positive threshold for this test is usually set at 10 ? g/g or 20 ? g/g, with higher values indicating greater bleeding and an increased risk of intestinal lesions such as colorectal cancer. Due to its ease of operation, rapid detection, high patient compliance, and better sensitivity and specificity, fecal immunochemical diagnostic testing has become the preferred method for large-scale screening of colorectal cancer worldwide, especially suitable for annual or biennial routine screening of the average risk population.
The industry chain of fecal immunochemical diagnostic testing covers upstream suppliers of core biological materials and fine consumables such as antigen antibody raw materials and nitrocellulose membranes, midstream manufacturers of reagent kits, analyzers, and supporting consumables (such as sampling tubes and fecal sampling sticks), as well as downstream application terminals such as hospital laboratories, physical examination centers, third-party medical laboratories, and home self testing. Regarding gross profit margin, the midstream of the industrial chain exhibits significant differentiation characteristics of 'high barriers and high gross profit': self owned brand manufacturers with core raw material self-produced capabilities and highly automated instrument platforms, relying on technological premiums and scale advantages, generally have high gross profit margins. Referring to similar projects in the in vitro diagnostic industry, the gross profit margin of high-tech threshold reagents such as chemiluminescence can reach over 90%, and the comprehensive gross profit margin of self owned products is about 70%; However, circulation enterprises or pure OEM manufacturers that mainly rely on agency sales have relatively low gross profit margins, usually around 40%, due to the need to offer discounts to brand owners.
The fecal immunochemical diagnostic test has been upgraded from a traditional qualitative screening 'suggestive tool' to a 'group defense line' in the global colorectal cancer prevention and control system that combines high compliance and high health economic value. Its revolutionary breakthrough lies in abandoning the strict restrictions of chemical methods on diet and medication, and accurately capturing trace amounts of gastrointestinal bleeding through specific anti human hemoglobin antibodies, thereby significantly improving the detection rate of early precancerous lesions (advanced adenomas) while significantly reducing the burden of unnecessary colonoscopy caused by false positives. It is not only the current optimal large-scale screening solution that balances 'sensitivity, specificity, cost, and convenience', but also a key pivot to promote colorectal cancer screening from 'passive diagnosis' to 'active prevention' - by establishing a positive threshold of 10 ? g/g stool, the disease prevention checkpoint is moved forward to the precancerous lesion stage, truly realizing the modern medical concept of 'screening is prevention'. The degree of promotion and popularization has directly become a core indicator for measuring the level of early diagnosis and treatment of colorectal cancer in a country.
This report studies the global Fecal Immunochemical Diagnostic Tests demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Fecal Immunochemical Diagnostic Tests, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Fecal Immunochemical Diagnostic Tests that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Fecal Immunochemical Diagnostic Tests total market, 2021-2032, (USD Million)
Global Fecal Immunochemical Diagnostic Tests total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Fecal Immunochemical Diagnostic Tests total market, key domestic companies, and share, (USD Million)
Global Fecal Immunochemical Diagnostic Tests revenue by player, revenue and market share 2021-2026, (USD Million)
Global Fecal Immunochemical Diagnostic Tests total market by Type, CAGR, 2021-2032, (USD Million)
Global Fecal Immunochemical Diagnostic Tests total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Fecal Immunochemical Diagnostic Tests market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eiken Chemical, Kyowa Medex, Alfresa Pharma Corporation, Sysmex Corporation, Fujirebio, Sentinel Diagnostics, R-Biopharm AG, Polymedco, Thermo Fisher Scientific, BioMerieux, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Fecal Immunochemical Diagnostic Tests market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Fecal Immunochemical Diagnostic Tests Market, By Region:
1. How big is the global Fecal Immunochemical Diagnostic Tests market?
2. What is the demand of the global Fecal Immunochemical Diagnostic Tests market?
3. What is the year over year growth of the global Fecal Immunochemical Diagnostic Tests market?
4. What is the total value of the global Fecal Immunochemical Diagnostic Tests market?
5. Who are the Major Players in the global Fecal Immunochemical Diagnostic Tests market?
6. What are the growth factors driving the market demand?
Fecal immunochemical diagnostic testing is a non-invasive diagnostic method based on the principle of antigen antibody specific reaction, which screens for lower gastrointestinal bleeding by detecting trace amounts of human hemoglobin in fecal samples. This test uses specific antibodies against human hemoglobin, which can accurately identify and measure the hemoglobin content in feces. The results are usually reported quantitatively or qualitatively in micrograms (? g/g) per gram of feces. Compared to traditional guaiacol based fecal occult blood testing, fecal immunochemical diagnostic testing has significant advantages: it does not require dietary restrictions (avoiding red meat or certain vegetables) or discontinuation of medication (such as vitamin C), as it specifically targets human hemoglobin and avoids peroxidase interference in food, thereby significantly reducing false positive rates. The positive threshold for this test is usually set at 10 ? g/g or 20 ? g/g, with higher values indicating greater bleeding and an increased risk of intestinal lesions such as colorectal cancer. Due to its ease of operation, rapid detection, high patient compliance, and better sensitivity and specificity, fecal immunochemical diagnostic testing has become the preferred method for large-scale screening of colorectal cancer worldwide, especially suitable for annual or biennial routine screening of the average risk population.
The industry chain of fecal immunochemical diagnostic testing covers upstream suppliers of core biological materials and fine consumables such as antigen antibody raw materials and nitrocellulose membranes, midstream manufacturers of reagent kits, analyzers, and supporting consumables (such as sampling tubes and fecal sampling sticks), as well as downstream application terminals such as hospital laboratories, physical examination centers, third-party medical laboratories, and home self testing. Regarding gross profit margin, the midstream of the industrial chain exhibits significant differentiation characteristics of 'high barriers and high gross profit': self owned brand manufacturers with core raw material self-produced capabilities and highly automated instrument platforms, relying on technological premiums and scale advantages, generally have high gross profit margins. Referring to similar projects in the in vitro diagnostic industry, the gross profit margin of high-tech threshold reagents such as chemiluminescence can reach over 90%, and the comprehensive gross profit margin of self owned products is about 70%; However, circulation enterprises or pure OEM manufacturers that mainly rely on agency sales have relatively low gross profit margins, usually around 40%, due to the need to offer discounts to brand owners.
The fecal immunochemical diagnostic test has been upgraded from a traditional qualitative screening 'suggestive tool' to a 'group defense line' in the global colorectal cancer prevention and control system that combines high compliance and high health economic value. Its revolutionary breakthrough lies in abandoning the strict restrictions of chemical methods on diet and medication, and accurately capturing trace amounts of gastrointestinal bleeding through specific anti human hemoglobin antibodies, thereby significantly improving the detection rate of early precancerous lesions (advanced adenomas) while significantly reducing the burden of unnecessary colonoscopy caused by false positives. It is not only the current optimal large-scale screening solution that balances 'sensitivity, specificity, cost, and convenience', but also a key pivot to promote colorectal cancer screening from 'passive diagnosis' to 'active prevention' - by establishing a positive threshold of 10 ? g/g stool, the disease prevention checkpoint is moved forward to the precancerous lesion stage, truly realizing the modern medical concept of 'screening is prevention'. The degree of promotion and popularization has directly become a core indicator for measuring the level of early diagnosis and treatment of colorectal cancer in a country.
This report studies the global Fecal Immunochemical Diagnostic Tests demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Fecal Immunochemical Diagnostic Tests, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Fecal Immunochemical Diagnostic Tests that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Fecal Immunochemical Diagnostic Tests total market, 2021-2032, (USD Million)
Global Fecal Immunochemical Diagnostic Tests total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Fecal Immunochemical Diagnostic Tests total market, key domestic companies, and share, (USD Million)
Global Fecal Immunochemical Diagnostic Tests revenue by player, revenue and market share 2021-2026, (USD Million)
Global Fecal Immunochemical Diagnostic Tests total market by Type, CAGR, 2021-2032, (USD Million)
Global Fecal Immunochemical Diagnostic Tests total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Fecal Immunochemical Diagnostic Tests market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eiken Chemical, Kyowa Medex, Alfresa Pharma Corporation, Sysmex Corporation, Fujirebio, Sentinel Diagnostics, R-Biopharm AG, Polymedco, Thermo Fisher Scientific, BioMerieux, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Fecal Immunochemical Diagnostic Tests market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Fecal Immunochemical Diagnostic Tests Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- High Sensitivity:>90%
- Moderate Sensitivity: 70% -90%
- Lower Sensitivity:<70%
- Qualitative Test
- Quantitative Test
- Immunoturbidimetry
- Immunochromatography
- Cancer Centers
- Nursing Homes
- Hospitals
- Homecare Settings
- Eiken Chemical
- Kyowa Medex
- Alfresa Pharma Corporation
- Sysmex Corporation
- Fujirebio
- Sentinel Diagnostics
- R-Biopharm AG
- Polymedco
- Thermo Fisher Scientific
- BioMerieux
- BTNX
- Hemosure
- Beckman Coulter
- Abbott Laboratories
- QuidelOrtho Corporation
- Roche Diagnostics
- Siemens Healthineers
- Innovita Biological Technology
- Ave Science & Technology
- Guangzhou Wondfo Biotech
1. How big is the global Fecal Immunochemical Diagnostic Tests market?
2. What is the demand of the global Fecal Immunochemical Diagnostic Tests market?
3. What is the year over year growth of the global Fecal Immunochemical Diagnostic Tests market?
4. What is the total value of the global Fecal Immunochemical Diagnostic Tests market?
5. Who are the Major Players in the global Fecal Immunochemical Diagnostic Tests market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Fecal Immunochemical Diagnostic Tests Introduction
1.2 World Fecal Immunochemical Diagnostic Tests Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Fecal Immunochemical Diagnostic Tests Total Market by Region (by Headquarter Location)
1.3.1 World Fecal Immunochemical Diagnostic Tests Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032)
1.3.3 China Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032)
1.3.4 Europe Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032)
1.3.5 Japan Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032)
1.3.6 South Korea Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032)
1.3.7 ASEAN Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032)
1.3.8 India Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Fecal Immunochemical Diagnostic Tests Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032)
2.2 World Fecal Immunochemical Diagnostic Tests Consumption Value by Region
2.2.1 World Fecal Immunochemical Diagnostic Tests Consumption Value by Region (2021-2026)
2.2.2 World Fecal Immunochemical Diagnostic Tests Consumption Value Forecast by Region (2027-2032)
2.3 United States Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032)
2.4 China Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032)
2.5 Europe Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032)
2.6 Japan Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032)
2.7 South Korea Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032)
2.8 ASEAN Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032)
2.9 India Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032)
3 WORLD FECAL IMMUNOCHEMICAL DIAGNOSTIC TESTS COMPANIES COMPETITIVE ANALYSIS
3.1 World Fecal Immunochemical Diagnostic Tests Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Fecal Immunochemical Diagnostic Tests Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Fecal Immunochemical Diagnostic Tests in 2025
3.2.3 Global Concentration Ratios (CR8) for Fecal Immunochemical Diagnostic Tests in 2025
3.3 Fecal Immunochemical Diagnostic Tests Company Evaluation Quadrant
3.4 Fecal Immunochemical Diagnostic Tests Market: Overall Company Footprint Analysis
3.4.1 Fecal Immunochemical Diagnostic Tests Market: Region Footprint
3.4.2 Fecal Immunochemical Diagnostic Tests Market: Company Product Type Footprint
3.4.3 Fecal Immunochemical Diagnostic Tests Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Fecal Immunochemical Diagnostic Tests Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Fecal Immunochemical Diagnostic Tests Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Fecal Immunochemical Diagnostic Tests Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Fecal Immunochemical Diagnostic Tests Consumption Value Comparison
4.2.1 United States VS China: Fecal Immunochemical Diagnostic Tests Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Fecal Immunochemical Diagnostic Tests Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Fecal Immunochemical Diagnostic Tests Companies and Market Share, 2021-2026
4.3.1 United States Based Fecal Immunochemical Diagnostic Tests Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Fecal Immunochemical Diagnostic Tests Revenue, (2021-2026)
4.4 China Based Companies Fecal Immunochemical Diagnostic Tests Revenue and Market Share, 2021-2026
4.4.1 China Based Fecal Immunochemical Diagnostic Tests Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Fecal Immunochemical Diagnostic Tests Revenue, (2021-2026)
4.5 Rest of World Based Fecal Immunochemical Diagnostic Tests Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Fecal Immunochemical Diagnostic Tests Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Fecal Immunochemical Diagnostic Tests Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Fecal Immunochemical Diagnostic Tests Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 High Sensitivity:>90%
5.2.2 Moderate Sensitivity: 70% -90%
5.2.3 Lower Sensitivity:<70%
5.3 Market Segment by Type
5.3.1 World Fecal Immunochemical Diagnostic Tests Market Size by Type (2021-2026)
5.3.2 World Fecal Immunochemical Diagnostic Tests Market Size by Type (2027-2032)
5.3.3 World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DATA PARAMETERS
6.1 World Fecal Immunochemical Diagnostic Tests Market Size Overview by Data Parameters: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Data Parameters
6.2.1 Qualitative Test
6.2.2 Quantitative Test
6.3 Market Segment by Data Parameters
6.3.1 World Fecal Immunochemical Diagnostic Tests Market Size by Data Parameters (2021-2026)
6.3.2 World Fecal Immunochemical Diagnostic Tests Market Size by Data Parameters (2027-2032)
6.3.3 World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Data Parameters (2027-2032)
7 MARKET ANALYSIS BY TECHNOLOGY PLATFORM
7.1 World Fecal Immunochemical Diagnostic Tests Market Size Overview by Technology Platform: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Technology Platform
7.2.1 Immunoturbidimetry
7.2.2 Immunochromatography
7.3 Market Segment by Technology Platform
7.3.1 World Fecal Immunochemical Diagnostic Tests Market Size by Technology Platform (2021-2026)
7.3.2 World Fecal Immunochemical Diagnostic Tests Market Size by Technology Platform (2027-2032)
7.3.3 World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Technology Platform (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Fecal Immunochemical Diagnostic Tests Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Cancer Centers
8.2.2 Nursing Homes
8.2.3 Hospitals
8.2.4 Homecare Settings
8.3 Market Segment by Application
8.3.1 World Fecal Immunochemical Diagnostic Tests Market Size by Application (2021-2026)
8.3.2 World Fecal Immunochemical Diagnostic Tests Market Size by Application (2027-2032)
8.3.3 World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Eiken Chemical
9.1.1 Eiken Chemical Details
9.1.2 Eiken Chemical Major Business
9.1.3 Eiken Chemical Fecal Immunochemical Diagnostic Tests Product and Services
9.1.4 Eiken Chemical Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Eiken Chemical Recent Developments/Updates
9.1.6 Eiken Chemical Competitive Strengths & Weaknesses
9.2 Kyowa Medex
9.2.1 Kyowa Medex Details
9.2.2 Kyowa Medex Major Business
9.2.3 Kyowa Medex Fecal Immunochemical Diagnostic Tests Product and Services
9.2.4 Kyowa Medex Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Kyowa Medex Recent Developments/Updates
9.2.6 Kyowa Medex Competitive Strengths & Weaknesses
9.3 Alfresa Pharma Corporation
9.3.1 Alfresa Pharma Corporation Details
9.3.2 Alfresa Pharma Corporation Major Business
9.3.3 Alfresa Pharma Corporation Fecal Immunochemical Diagnostic Tests Product and Services
9.3.4 Alfresa Pharma Corporation Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Alfresa Pharma Corporation Recent Developments/Updates
9.3.6 Alfresa Pharma Corporation Competitive Strengths & Weaknesses
9.4 Sysmex Corporation
9.4.1 Sysmex Corporation Details
9.4.2 Sysmex Corporation Major Business
9.4.3 Sysmex Corporation Fecal Immunochemical Diagnostic Tests Product and Services
9.4.4 Sysmex Corporation Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Sysmex Corporation Recent Developments/Updates
9.4.6 Sysmex Corporation Competitive Strengths & Weaknesses
9.5 Fujirebio
9.5.1 Fujirebio Details
9.5.2 Fujirebio Major Business
9.5.3 Fujirebio Fecal Immunochemical Diagnostic Tests Product and Services
9.5.4 Fujirebio Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Fujirebio Recent Developments/Updates
9.5.6 Fujirebio Competitive Strengths & Weaknesses
9.6 Sentinel Diagnostics
9.6.1 Sentinel Diagnostics Details
9.6.2 Sentinel Diagnostics Major Business
9.6.3 Sentinel Diagnostics Fecal Immunochemical Diagnostic Tests Product and Services
9.6.4 Sentinel Diagnostics Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Sentinel Diagnostics Recent Developments/Updates
9.6.6 Sentinel Diagnostics Competitive Strengths & Weaknesses
9.7 R-Biopharm AG
9.7.1 R-Biopharm AG Details
9.7.2 R-Biopharm AG Major Business
9.7.3 R-Biopharm AG Fecal Immunochemical Diagnostic Tests Product and Services
9.7.4 R-Biopharm AG Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 R-Biopharm AG Recent Developments/Updates
9.7.6 R-Biopharm AG Competitive Strengths & Weaknesses
9.8 Polymedco
9.8.1 Polymedco Details
9.8.2 Polymedco Major Business
9.8.3 Polymedco Fecal Immunochemical Diagnostic Tests Product and Services
9.8.4 Polymedco Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Polymedco Recent Developments/Updates
9.8.6 Polymedco Competitive Strengths & Weaknesses
9.9 Thermo Fisher Scientific
9.9.1 Thermo Fisher Scientific Details
9.9.2 Thermo Fisher Scientific Major Business
9.9.3 Thermo Fisher Scientific Fecal Immunochemical Diagnostic Tests Product and Services
9.9.4 Thermo Fisher Scientific Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Thermo Fisher Scientific Recent Developments/Updates
9.9.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.10 BioMerieux
9.10.1 BioMerieux Details
9.10.2 BioMerieux Major Business
9.10.3 BioMerieux Fecal Immunochemical Diagnostic Tests Product and Services
9.10.4 BioMerieux Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 BioMerieux Recent Developments/Updates
9.10.6 BioMerieux Competitive Strengths & Weaknesses
9.11 BTNX
9.11.1 BTNX Details
9.11.2 BTNX Major Business
9.11.3 BTNX Fecal Immunochemical Diagnostic Tests Product and Services
9.11.4 BTNX Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 BTNX Recent Developments/Updates
9.11.6 BTNX Competitive Strengths & Weaknesses
9.12 Hemosure
9.12.1 Hemosure Details
9.12.2 Hemosure Major Business
9.12.3 Hemosure Fecal Immunochemical Diagnostic Tests Product and Services
9.12.4 Hemosure Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Hemosure Recent Developments/Updates
9.12.6 Hemosure Competitive Strengths & Weaknesses
9.13 Beckman Coulter
9.13.1 Beckman Coulter Details
9.13.2 Beckman Coulter Major Business
9.13.3 Beckman Coulter Fecal Immunochemical Diagnostic Tests Product and Services
9.13.4 Beckman Coulter Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Beckman Coulter Recent Developments/Updates
9.13.6 Beckman Coulter Competitive Strengths & Weaknesses
9.14 Abbott Laboratories
9.14.1 Abbott Laboratories Details
9.14.2 Abbott Laboratories Major Business
9.14.3 Abbott Laboratories Fecal Immunochemical Diagnostic Tests Product and Services
9.14.4 Abbott Laboratories Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Abbott Laboratories Recent Developments/Updates
9.14.6 Abbott Laboratories Competitive Strengths & Weaknesses
9.15 QuidelOrtho Corporation
9.15.1 QuidelOrtho Corporation Details
9.15.2 QuidelOrtho Corporation Major Business
9.15.3 QuidelOrtho Corporation Fecal Immunochemical Diagnostic Tests Product and Services
9.15.4 QuidelOrtho Corporation Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 QuidelOrtho Corporation Recent Developments/Updates
9.15.6 QuidelOrtho Corporation Competitive Strengths & Weaknesses
9.16 Roche Diagnostics
9.16.1 Roche Diagnostics Details
9.16.2 Roche Diagnostics Major Business
9.16.3 Roche Diagnostics Fecal Immunochemical Diagnostic Tests Product and Services
9.16.4 Roche Diagnostics Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Roche Diagnostics Recent Developments/Updates
9.16.6 Roche Diagnostics Competitive Strengths & Weaknesses
9.17 Siemens Healthineers
9.17.1 Siemens Healthineers Details
9.17.2 Siemens Healthineers Major Business
9.17.3 Siemens Healthineers Fecal Immunochemical Diagnostic Tests Product and Services
9.17.4 Siemens Healthineers Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Siemens Healthineers Recent Developments/Updates
9.17.6 Siemens Healthineers Competitive Strengths & Weaknesses
9.18 Innovita Biological Technology
9.18.1 Innovita Biological Technology Details
9.18.2 Innovita Biological Technology Major Business
9.18.3 Innovita Biological Technology Fecal Immunochemical Diagnostic Tests Product and Services
9.18.4 Innovita Biological Technology Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Innovita Biological Technology Recent Developments/Updates
9.18.6 Innovita Biological Technology Competitive Strengths & Weaknesses
9.19 Ave Science & Technology
9.19.1 Ave Science & Technology Details
9.19.2 Ave Science & Technology Major Business
9.19.3 Ave Science & Technology Fecal Immunochemical Diagnostic Tests Product and Services
9.19.4 Ave Science & Technology Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Ave Science & Technology Recent Developments/Updates
9.19.6 Ave Science & Technology Competitive Strengths & Weaknesses
9.20 Guangzhou Wondfo Biotech
9.20.1 Guangzhou Wondfo Biotech Details
9.20.2 Guangzhou Wondfo Biotech Major Business
9.20.3 Guangzhou Wondfo Biotech Fecal Immunochemical Diagnostic Tests Product and Services
9.20.4 Guangzhou Wondfo Biotech Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Guangzhou Wondfo Biotech Recent Developments/Updates
9.20.6 Guangzhou Wondfo Biotech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Fecal Immunochemical Diagnostic Tests Industry Chain
10.2 Fecal Immunochemical Diagnostic Tests Upstream Analysis
10.3 Fecal Immunochemical Diagnostic Tests Midstream Analysis
10.4 Fecal Immunochemical Diagnostic Tests Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Fecal Immunochemical Diagnostic Tests Introduction
1.2 World Fecal Immunochemical Diagnostic Tests Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Fecal Immunochemical Diagnostic Tests Total Market by Region (by Headquarter Location)
1.3.1 World Fecal Immunochemical Diagnostic Tests Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032)
1.3.3 China Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032)
1.3.4 Europe Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032)
1.3.5 Japan Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032)
1.3.6 South Korea Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032)
1.3.7 ASEAN Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032)
1.3.8 India Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Fecal Immunochemical Diagnostic Tests Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032)
2.2 World Fecal Immunochemical Diagnostic Tests Consumption Value by Region
2.2.1 World Fecal Immunochemical Diagnostic Tests Consumption Value by Region (2021-2026)
2.2.2 World Fecal Immunochemical Diagnostic Tests Consumption Value Forecast by Region (2027-2032)
2.3 United States Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032)
2.4 China Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032)
2.5 Europe Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032)
2.6 Japan Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032)
2.7 South Korea Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032)
2.8 ASEAN Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032)
2.9 India Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032)
3 WORLD FECAL IMMUNOCHEMICAL DIAGNOSTIC TESTS COMPANIES COMPETITIVE ANALYSIS
3.1 World Fecal Immunochemical Diagnostic Tests Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Fecal Immunochemical Diagnostic Tests Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Fecal Immunochemical Diagnostic Tests in 2025
3.2.3 Global Concentration Ratios (CR8) for Fecal Immunochemical Diagnostic Tests in 2025
3.3 Fecal Immunochemical Diagnostic Tests Company Evaluation Quadrant
3.4 Fecal Immunochemical Diagnostic Tests Market: Overall Company Footprint Analysis
3.4.1 Fecal Immunochemical Diagnostic Tests Market: Region Footprint
3.4.2 Fecal Immunochemical Diagnostic Tests Market: Company Product Type Footprint
3.4.3 Fecal Immunochemical Diagnostic Tests Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Fecal Immunochemical Diagnostic Tests Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Fecal Immunochemical Diagnostic Tests Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Fecal Immunochemical Diagnostic Tests Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Fecal Immunochemical Diagnostic Tests Consumption Value Comparison
4.2.1 United States VS China: Fecal Immunochemical Diagnostic Tests Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Fecal Immunochemical Diagnostic Tests Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Fecal Immunochemical Diagnostic Tests Companies and Market Share, 2021-2026
4.3.1 United States Based Fecal Immunochemical Diagnostic Tests Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Fecal Immunochemical Diagnostic Tests Revenue, (2021-2026)
4.4 China Based Companies Fecal Immunochemical Diagnostic Tests Revenue and Market Share, 2021-2026
4.4.1 China Based Fecal Immunochemical Diagnostic Tests Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Fecal Immunochemical Diagnostic Tests Revenue, (2021-2026)
4.5 Rest of World Based Fecal Immunochemical Diagnostic Tests Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Fecal Immunochemical Diagnostic Tests Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Fecal Immunochemical Diagnostic Tests Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Fecal Immunochemical Diagnostic Tests Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 High Sensitivity:>90%
5.2.2 Moderate Sensitivity: 70% -90%
5.2.3 Lower Sensitivity:<70%
5.3 Market Segment by Type
5.3.1 World Fecal Immunochemical Diagnostic Tests Market Size by Type (2021-2026)
5.3.2 World Fecal Immunochemical Diagnostic Tests Market Size by Type (2027-2032)
5.3.3 World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DATA PARAMETERS
6.1 World Fecal Immunochemical Diagnostic Tests Market Size Overview by Data Parameters: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Data Parameters
6.2.1 Qualitative Test
6.2.2 Quantitative Test
6.3 Market Segment by Data Parameters
6.3.1 World Fecal Immunochemical Diagnostic Tests Market Size by Data Parameters (2021-2026)
6.3.2 World Fecal Immunochemical Diagnostic Tests Market Size by Data Parameters (2027-2032)
6.3.3 World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Data Parameters (2027-2032)
7 MARKET ANALYSIS BY TECHNOLOGY PLATFORM
7.1 World Fecal Immunochemical Diagnostic Tests Market Size Overview by Technology Platform: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Technology Platform
7.2.1 Immunoturbidimetry
7.2.2 Immunochromatography
7.3 Market Segment by Technology Platform
7.3.1 World Fecal Immunochemical Diagnostic Tests Market Size by Technology Platform (2021-2026)
7.3.2 World Fecal Immunochemical Diagnostic Tests Market Size by Technology Platform (2027-2032)
7.3.3 World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Technology Platform (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Fecal Immunochemical Diagnostic Tests Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Cancer Centers
8.2.2 Nursing Homes
8.2.3 Hospitals
8.2.4 Homecare Settings
8.3 Market Segment by Application
8.3.1 World Fecal Immunochemical Diagnostic Tests Market Size by Application (2021-2026)
8.3.2 World Fecal Immunochemical Diagnostic Tests Market Size by Application (2027-2032)
8.3.3 World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Eiken Chemical
9.1.1 Eiken Chemical Details
9.1.2 Eiken Chemical Major Business
9.1.3 Eiken Chemical Fecal Immunochemical Diagnostic Tests Product and Services
9.1.4 Eiken Chemical Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Eiken Chemical Recent Developments/Updates
9.1.6 Eiken Chemical Competitive Strengths & Weaknesses
9.2 Kyowa Medex
9.2.1 Kyowa Medex Details
9.2.2 Kyowa Medex Major Business
9.2.3 Kyowa Medex Fecal Immunochemical Diagnostic Tests Product and Services
9.2.4 Kyowa Medex Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Kyowa Medex Recent Developments/Updates
9.2.6 Kyowa Medex Competitive Strengths & Weaknesses
9.3 Alfresa Pharma Corporation
9.3.1 Alfresa Pharma Corporation Details
9.3.2 Alfresa Pharma Corporation Major Business
9.3.3 Alfresa Pharma Corporation Fecal Immunochemical Diagnostic Tests Product and Services
9.3.4 Alfresa Pharma Corporation Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Alfresa Pharma Corporation Recent Developments/Updates
9.3.6 Alfresa Pharma Corporation Competitive Strengths & Weaknesses
9.4 Sysmex Corporation
9.4.1 Sysmex Corporation Details
9.4.2 Sysmex Corporation Major Business
9.4.3 Sysmex Corporation Fecal Immunochemical Diagnostic Tests Product and Services
9.4.4 Sysmex Corporation Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Sysmex Corporation Recent Developments/Updates
9.4.6 Sysmex Corporation Competitive Strengths & Weaknesses
9.5 Fujirebio
9.5.1 Fujirebio Details
9.5.2 Fujirebio Major Business
9.5.3 Fujirebio Fecal Immunochemical Diagnostic Tests Product and Services
9.5.4 Fujirebio Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Fujirebio Recent Developments/Updates
9.5.6 Fujirebio Competitive Strengths & Weaknesses
9.6 Sentinel Diagnostics
9.6.1 Sentinel Diagnostics Details
9.6.2 Sentinel Diagnostics Major Business
9.6.3 Sentinel Diagnostics Fecal Immunochemical Diagnostic Tests Product and Services
9.6.4 Sentinel Diagnostics Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Sentinel Diagnostics Recent Developments/Updates
9.6.6 Sentinel Diagnostics Competitive Strengths & Weaknesses
9.7 R-Biopharm AG
9.7.1 R-Biopharm AG Details
9.7.2 R-Biopharm AG Major Business
9.7.3 R-Biopharm AG Fecal Immunochemical Diagnostic Tests Product and Services
9.7.4 R-Biopharm AG Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 R-Biopharm AG Recent Developments/Updates
9.7.6 R-Biopharm AG Competitive Strengths & Weaknesses
9.8 Polymedco
9.8.1 Polymedco Details
9.8.2 Polymedco Major Business
9.8.3 Polymedco Fecal Immunochemical Diagnostic Tests Product and Services
9.8.4 Polymedco Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Polymedco Recent Developments/Updates
9.8.6 Polymedco Competitive Strengths & Weaknesses
9.9 Thermo Fisher Scientific
9.9.1 Thermo Fisher Scientific Details
9.9.2 Thermo Fisher Scientific Major Business
9.9.3 Thermo Fisher Scientific Fecal Immunochemical Diagnostic Tests Product and Services
9.9.4 Thermo Fisher Scientific Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Thermo Fisher Scientific Recent Developments/Updates
9.9.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.10 BioMerieux
9.10.1 BioMerieux Details
9.10.2 BioMerieux Major Business
9.10.3 BioMerieux Fecal Immunochemical Diagnostic Tests Product and Services
9.10.4 BioMerieux Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 BioMerieux Recent Developments/Updates
9.10.6 BioMerieux Competitive Strengths & Weaknesses
9.11 BTNX
9.11.1 BTNX Details
9.11.2 BTNX Major Business
9.11.3 BTNX Fecal Immunochemical Diagnostic Tests Product and Services
9.11.4 BTNX Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 BTNX Recent Developments/Updates
9.11.6 BTNX Competitive Strengths & Weaknesses
9.12 Hemosure
9.12.1 Hemosure Details
9.12.2 Hemosure Major Business
9.12.3 Hemosure Fecal Immunochemical Diagnostic Tests Product and Services
9.12.4 Hemosure Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Hemosure Recent Developments/Updates
9.12.6 Hemosure Competitive Strengths & Weaknesses
9.13 Beckman Coulter
9.13.1 Beckman Coulter Details
9.13.2 Beckman Coulter Major Business
9.13.3 Beckman Coulter Fecal Immunochemical Diagnostic Tests Product and Services
9.13.4 Beckman Coulter Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Beckman Coulter Recent Developments/Updates
9.13.6 Beckman Coulter Competitive Strengths & Weaknesses
9.14 Abbott Laboratories
9.14.1 Abbott Laboratories Details
9.14.2 Abbott Laboratories Major Business
9.14.3 Abbott Laboratories Fecal Immunochemical Diagnostic Tests Product and Services
9.14.4 Abbott Laboratories Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Abbott Laboratories Recent Developments/Updates
9.14.6 Abbott Laboratories Competitive Strengths & Weaknesses
9.15 QuidelOrtho Corporation
9.15.1 QuidelOrtho Corporation Details
9.15.2 QuidelOrtho Corporation Major Business
9.15.3 QuidelOrtho Corporation Fecal Immunochemical Diagnostic Tests Product and Services
9.15.4 QuidelOrtho Corporation Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 QuidelOrtho Corporation Recent Developments/Updates
9.15.6 QuidelOrtho Corporation Competitive Strengths & Weaknesses
9.16 Roche Diagnostics
9.16.1 Roche Diagnostics Details
9.16.2 Roche Diagnostics Major Business
9.16.3 Roche Diagnostics Fecal Immunochemical Diagnostic Tests Product and Services
9.16.4 Roche Diagnostics Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Roche Diagnostics Recent Developments/Updates
9.16.6 Roche Diagnostics Competitive Strengths & Weaknesses
9.17 Siemens Healthineers
9.17.1 Siemens Healthineers Details
9.17.2 Siemens Healthineers Major Business
9.17.3 Siemens Healthineers Fecal Immunochemical Diagnostic Tests Product and Services
9.17.4 Siemens Healthineers Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Siemens Healthineers Recent Developments/Updates
9.17.6 Siemens Healthineers Competitive Strengths & Weaknesses
9.18 Innovita Biological Technology
9.18.1 Innovita Biological Technology Details
9.18.2 Innovita Biological Technology Major Business
9.18.3 Innovita Biological Technology Fecal Immunochemical Diagnostic Tests Product and Services
9.18.4 Innovita Biological Technology Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Innovita Biological Technology Recent Developments/Updates
9.18.6 Innovita Biological Technology Competitive Strengths & Weaknesses
9.19 Ave Science & Technology
9.19.1 Ave Science & Technology Details
9.19.2 Ave Science & Technology Major Business
9.19.3 Ave Science & Technology Fecal Immunochemical Diagnostic Tests Product and Services
9.19.4 Ave Science & Technology Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Ave Science & Technology Recent Developments/Updates
9.19.6 Ave Science & Technology Competitive Strengths & Weaknesses
9.20 Guangzhou Wondfo Biotech
9.20.1 Guangzhou Wondfo Biotech Details
9.20.2 Guangzhou Wondfo Biotech Major Business
9.20.3 Guangzhou Wondfo Biotech Fecal Immunochemical Diagnostic Tests Product and Services
9.20.4 Guangzhou Wondfo Biotech Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Guangzhou Wondfo Biotech Recent Developments/Updates
9.20.6 Guangzhou Wondfo Biotech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Fecal Immunochemical Diagnostic Tests Industry Chain
10.2 Fecal Immunochemical Diagnostic Tests Upstream Analysis
10.3 Fecal Immunochemical Diagnostic Tests Midstream Analysis
10.4 Fecal Immunochemical Diagnostic Tests Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Fecal Immunochemical Diagnostic Tests Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Fecal Immunochemical Diagnostic Tests Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Fecal Immunochemical Diagnostic Tests Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Fecal Immunochemical Diagnostic Tests Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Fecal Immunochemical Diagnostic Tests Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Fecal Immunochemical Diagnostic Tests Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Fecal Immunochemical Diagnostic Tests Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Fecal Immunochemical Diagnostic Tests Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Fecal Immunochemical Diagnostic Tests Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Fecal Immunochemical Diagnostic Tests Players in 2025
Table 12. World Fecal Immunochemical Diagnostic Tests Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Fecal Immunochemical Diagnostic Tests Company Evaluation Quadrant
Table 14. Head Office of Key Fecal Immunochemical Diagnostic Tests Players
Table 15. Fecal Immunochemical Diagnostic Tests Market: Company Product Type Footprint
Table 16. Fecal Immunochemical Diagnostic Tests Market: Company Product Application Footprint
Table 17. Fecal Immunochemical Diagnostic Tests Mergers & Acquisitions Activity
Table 18. United States VS China Fecal Immunochemical Diagnostic Tests Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Fecal Immunochemical Diagnostic Tests Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Fecal Immunochemical Diagnostic Tests Companies, Headquarters (States, Country)
Table 21. United States Based Companies Fecal Immunochemical Diagnostic Tests Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Fecal Immunochemical Diagnostic Tests Revenue Market Share (2021-2026)
Table 23. China Based Fecal Immunochemical Diagnostic Tests Companies, Headquarters (Province, Country)
Table 24. China Based Companies Fecal Immunochemical Diagnostic Tests Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Fecal Immunochemical Diagnostic Tests Revenue Market Share (2021-2026)
Table 26. Rest of World Based Fecal Immunochemical Diagnostic Tests Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Fecal Immunochemical Diagnostic Tests Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Fecal Immunochemical Diagnostic Tests Revenue Market Share (2021-2026)
Table 29. World Fecal Immunochemical Diagnostic Tests Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Fecal Immunochemical Diagnostic Tests Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Fecal Immunochemical Diagnostic Tests Market Size by Type (2027-2032) & (USD Million)
Table 32. World Fecal Immunochemical Diagnostic Tests Market Size by Data Parameters, (USD Million), 2021 & 2025 & 2032
Table 33. World Fecal Immunochemical Diagnostic Tests Market Size Value by Data Parameters (2021-2026) & (USD Million)
Table 34. World Fecal Immunochemical Diagnostic Tests Market Size by Data Parameters (2027-2032) & (USD Million)
Table 35. World Fecal Immunochemical Diagnostic Tests Market Size by Technology Platform, (USD Million), 2021 & 2025 & 2032
Table 36. World Fecal Immunochemical Diagnostic Tests Market Size Value by Technology Platform (2021-2026) & (USD Million)
Table 37. World Fecal Immunochemical Diagnostic Tests Market Size by Technology Platform (2027-2032) & (USD Million)
Table 38. World Fecal Immunochemical Diagnostic Tests Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Fecal Immunochemical Diagnostic Tests Market Size by Application (2021-2026) & (USD Million)
Table 40. World Fecal Immunochemical Diagnostic Tests Market Size by Application (2027-2032) & (USD Million)
Table 41. Eiken Chemical Basic Information, Manufacturing Base and Competitors
Table 42. Eiken Chemical Major Business
Table 43. Eiken Chemical Fecal Immunochemical Diagnostic Tests Product and Services
Table 44. Eiken Chemical Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Eiken Chemical Recent Developments/Updates
Table 46. Eiken Chemical Competitive Strengths & Weaknesses
Table 47. Kyowa Medex Basic Information, Manufacturing Base and Competitors
Table 48. Kyowa Medex Major Business
Table 49. Kyowa Medex Fecal Immunochemical Diagnostic Tests Product and Services
Table 50. Kyowa Medex Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Kyowa Medex Recent Developments/Updates
Table 52. Kyowa Medex Competitive Strengths & Weaknesses
Table 53. Alfresa Pharma Corporation Basic Information, Manufacturing Base and Competitors
Table 54. Alfresa Pharma Corporation Major Business
Table 55. Alfresa Pharma Corporation Fecal Immunochemical Diagnostic Tests Product and Services
Table 56. Alfresa Pharma Corporation Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Alfresa Pharma Corporation Recent Developments/Updates
Table 58. Alfresa Pharma Corporation Competitive Strengths & Weaknesses
Table 59. Sysmex Corporation Basic Information, Manufacturing Base and Competitors
Table 60. Sysmex Corporation Major Business
Table 61. Sysmex Corporation Fecal Immunochemical Diagnostic Tests Product and Services
Table 62. Sysmex Corporation Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Sysmex Corporation Recent Developments/Updates
Table 64. Sysmex Corporation Competitive Strengths & Weaknesses
Table 65. Fujirebio Basic Information, Manufacturing Base and Competitors
Table 66. Fujirebio Major Business
Table 67. Fujirebio Fecal Immunochemical Diagnostic Tests Product and Services
Table 68. Fujirebio Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Fujirebio Recent Developments/Updates
Table 70. Fujirebio Competitive Strengths & Weaknesses
Table 71. Sentinel Diagnostics Basic Information, Manufacturing Base and Competitors
Table 72. Sentinel Diagnostics Major Business
Table 73. Sentinel Diagnostics Fecal Immunochemical Diagnostic Tests Product and Services
Table 74. Sentinel Diagnostics Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Sentinel Diagnostics Recent Developments/Updates
Table 76. Sentinel Diagnostics Competitive Strengths & Weaknesses
Table 77. R-Biopharm AG Basic Information, Manufacturing Base and Competitors
Table 78. R-Biopharm AG Major Business
Table 79. R-Biopharm AG Fecal Immunochemical Diagnostic Tests Product and Services
Table 80. R-Biopharm AG Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. R-Biopharm AG Recent Developments/Updates
Table 82. R-Biopharm AG Competitive Strengths & Weaknesses
Table 83. Polymedco Basic Information, Manufacturing Base and Competitors
Table 84. Polymedco Major Business
Table 85. Polymedco Fecal Immunochemical Diagnostic Tests Product and Services
Table 86. Polymedco Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Polymedco Recent Developments/Updates
Table 88. Polymedco Competitive Strengths & Weaknesses
Table 89. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 90. Thermo Fisher Scientific Major Business
Table 91. Thermo Fisher Scientific Fecal Immunochemical Diagnostic Tests Product and Services
Table 92. Thermo Fisher Scientific Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Thermo Fisher Scientific Recent Developments/Updates
Table 94. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 95. BioMerieux Basic Information, Manufacturing Base and Competitors
Table 96. BioMerieux Major Business
Table 97. BioMerieux Fecal Immunochemical Diagnostic Tests Product and Services
Table 98. BioMerieux Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. BioMerieux Recent Developments/Updates
Table 100. BioMerieux Competitive Strengths & Weaknesses
Table 101. BTNX Basic Information, Manufacturing Base and Competitors
Table 102. BTNX Major Business
Table 103. BTNX Fecal Immunochemical Diagnostic Tests Product and Services
Table 104. BTNX Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. BTNX Recent Developments/Updates
Table 106. BTNX Competitive Strengths & Weaknesses
Table 107. Hemosure Basic Information, Manufacturing Base and Competitors
Table 108. Hemosure Major Business
Table 109. Hemosure Fecal Immunochemical Diagnostic Tests Product and Services
Table 110. Hemosure Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Hemosure Recent Developments/Updates
Table 112. Hemosure Competitive Strengths & Weaknesses
Table 113. Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table 114. Beckman Coulter Major Business
Table 115. Beckman Coulter Fecal Immunochemical Diagnostic Tests Product and Services
Table 116. Beckman Coulter Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Beckman Coulter Recent Developments/Updates
Table 118. Beckman Coulter Competitive Strengths & Weaknesses
Table 119. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 120. Abbott Laboratories Major Business
Table 121. Abbott Laboratories Fecal Immunochemical Diagnostic Tests Product and Services
Table 122. Abbott Laboratories Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Abbott Laboratories Recent Developments/Updates
Table 124. Abbott Laboratories Competitive Strengths & Weaknesses
Table 125. QuidelOrtho Corporation Basic Information, Manufacturing Base and Competitors
Table 126. QuidelOrtho Corporation Major Business
Table 127. QuidelOrtho Corporation Fecal Immunochemical Diagnostic Tests Product and Services
Table 128. QuidelOrtho Corporation Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. QuidelOrtho Corporation Recent Developments/Updates
Table 130. QuidelOrtho Corporation Competitive Strengths & Weaknesses
Table 131. Roche Diagnostics Basic Information, Manufacturing Base and Competitors
Table 132. Roche Diagnostics Major Business
Table 133. Roche Diagnostics Fecal Immunochemical Diagnostic Tests Product and Services
Table 134. Roche Diagnostics Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Roche Diagnostics Recent Developments/Updates
Table 136. Roche Diagnostics Competitive Strengths & Weaknesses
Table 137. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 138. Siemens Healthineers Major Business
Table 139. Siemens Healthineers Fecal Immunochemical Diagnostic Tests Product and Services
Table 140. Siemens Healthineers Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Siemens Healthineers Recent Developments/Updates
Table 142. Siemens Healthineers Competitive Strengths & Weaknesses
Table 143. Innovita?Biological?Technology Basic Information, Manufacturing Base and Competitors
Table 144. Innovita?Biological?Technology Major Business
Table 145. Innovita?Biological?Technology Fecal Immunochemical Diagnostic Tests Product and Services
Table 146. Innovita?Biological?Technology Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Innovita?Biological?Technology Recent Developments/Updates
Table 148. Innovita?Biological?Technology Competitive Strengths & Weaknesses
Table 149. Ave?Science & Technology Basic Information, Manufacturing Base and Competitors
Table 150. Ave?Science & Technology Major Business
Table 151. Ave?Science & Technology Fecal Immunochemical Diagnostic Tests Product and Services
Table 152. Ave?Science & Technology Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Ave?Science & Technology Recent Developments/Updates
Table 154. Ave?Science & Technology Competitive Strengths & Weaknesses
Table 155. Guangzhou Wondfo Biotech Basic Information, Manufacturing Base and Competitors
Table 156. Guangzhou Wondfo Biotech Major Business
Table 157. Guangzhou Wondfo Biotech Fecal Immunochemical Diagnostic Tests Product and Services
Table 158. Guangzhou Wondfo Biotech Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Guangzhou Wondfo Biotech Recent Developments/Updates
Table 160. Guangzhou Wondfo Biotech Competitive Strengths & Weaknesses
Table 161. Global Key Players of Fecal Immunochemical Diagnostic Tests Upstream (Raw Materials)
Table 162. Global Fecal Immunochemical Diagnostic Tests Typical Customers
Table 1. World Fecal Immunochemical Diagnostic Tests Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Fecal Immunochemical Diagnostic Tests Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Fecal Immunochemical Diagnostic Tests Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Fecal Immunochemical Diagnostic Tests Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Fecal Immunochemical Diagnostic Tests Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Fecal Immunochemical Diagnostic Tests Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Fecal Immunochemical Diagnostic Tests Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Fecal Immunochemical Diagnostic Tests Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Fecal Immunochemical Diagnostic Tests Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Fecal Immunochemical Diagnostic Tests Players in 2025
Table 12. World Fecal Immunochemical Diagnostic Tests Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Fecal Immunochemical Diagnostic Tests Company Evaluation Quadrant
Table 14. Head Office of Key Fecal Immunochemical Diagnostic Tests Players
Table 15. Fecal Immunochemical Diagnostic Tests Market: Company Product Type Footprint
Table 16. Fecal Immunochemical Diagnostic Tests Market: Company Product Application Footprint
Table 17. Fecal Immunochemical Diagnostic Tests Mergers & Acquisitions Activity
Table 18. United States VS China Fecal Immunochemical Diagnostic Tests Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Fecal Immunochemical Diagnostic Tests Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Fecal Immunochemical Diagnostic Tests Companies, Headquarters (States, Country)
Table 21. United States Based Companies Fecal Immunochemical Diagnostic Tests Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Fecal Immunochemical Diagnostic Tests Revenue Market Share (2021-2026)
Table 23. China Based Fecal Immunochemical Diagnostic Tests Companies, Headquarters (Province, Country)
Table 24. China Based Companies Fecal Immunochemical Diagnostic Tests Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Fecal Immunochemical Diagnostic Tests Revenue Market Share (2021-2026)
Table 26. Rest of World Based Fecal Immunochemical Diagnostic Tests Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Fecal Immunochemical Diagnostic Tests Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Fecal Immunochemical Diagnostic Tests Revenue Market Share (2021-2026)
Table 29. World Fecal Immunochemical Diagnostic Tests Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Fecal Immunochemical Diagnostic Tests Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Fecal Immunochemical Diagnostic Tests Market Size by Type (2027-2032) & (USD Million)
Table 32. World Fecal Immunochemical Diagnostic Tests Market Size by Data Parameters, (USD Million), 2021 & 2025 & 2032
Table 33. World Fecal Immunochemical Diagnostic Tests Market Size Value by Data Parameters (2021-2026) & (USD Million)
Table 34. World Fecal Immunochemical Diagnostic Tests Market Size by Data Parameters (2027-2032) & (USD Million)
Table 35. World Fecal Immunochemical Diagnostic Tests Market Size by Technology Platform, (USD Million), 2021 & 2025 & 2032
Table 36. World Fecal Immunochemical Diagnostic Tests Market Size Value by Technology Platform (2021-2026) & (USD Million)
Table 37. World Fecal Immunochemical Diagnostic Tests Market Size by Technology Platform (2027-2032) & (USD Million)
Table 38. World Fecal Immunochemical Diagnostic Tests Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Fecal Immunochemical Diagnostic Tests Market Size by Application (2021-2026) & (USD Million)
Table 40. World Fecal Immunochemical Diagnostic Tests Market Size by Application (2027-2032) & (USD Million)
Table 41. Eiken Chemical Basic Information, Manufacturing Base and Competitors
Table 42. Eiken Chemical Major Business
Table 43. Eiken Chemical Fecal Immunochemical Diagnostic Tests Product and Services
Table 44. Eiken Chemical Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Eiken Chemical Recent Developments/Updates
Table 46. Eiken Chemical Competitive Strengths & Weaknesses
Table 47. Kyowa Medex Basic Information, Manufacturing Base and Competitors
Table 48. Kyowa Medex Major Business
Table 49. Kyowa Medex Fecal Immunochemical Diagnostic Tests Product and Services
Table 50. Kyowa Medex Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Kyowa Medex Recent Developments/Updates
Table 52. Kyowa Medex Competitive Strengths & Weaknesses
Table 53. Alfresa Pharma Corporation Basic Information, Manufacturing Base and Competitors
Table 54. Alfresa Pharma Corporation Major Business
Table 55. Alfresa Pharma Corporation Fecal Immunochemical Diagnostic Tests Product and Services
Table 56. Alfresa Pharma Corporation Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Alfresa Pharma Corporation Recent Developments/Updates
Table 58. Alfresa Pharma Corporation Competitive Strengths & Weaknesses
Table 59. Sysmex Corporation Basic Information, Manufacturing Base and Competitors
Table 60. Sysmex Corporation Major Business
Table 61. Sysmex Corporation Fecal Immunochemical Diagnostic Tests Product and Services
Table 62. Sysmex Corporation Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Sysmex Corporation Recent Developments/Updates
Table 64. Sysmex Corporation Competitive Strengths & Weaknesses
Table 65. Fujirebio Basic Information, Manufacturing Base and Competitors
Table 66. Fujirebio Major Business
Table 67. Fujirebio Fecal Immunochemical Diagnostic Tests Product and Services
Table 68. Fujirebio Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Fujirebio Recent Developments/Updates
Table 70. Fujirebio Competitive Strengths & Weaknesses
Table 71. Sentinel Diagnostics Basic Information, Manufacturing Base and Competitors
Table 72. Sentinel Diagnostics Major Business
Table 73. Sentinel Diagnostics Fecal Immunochemical Diagnostic Tests Product and Services
Table 74. Sentinel Diagnostics Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Sentinel Diagnostics Recent Developments/Updates
Table 76. Sentinel Diagnostics Competitive Strengths & Weaknesses
Table 77. R-Biopharm AG Basic Information, Manufacturing Base and Competitors
Table 78. R-Biopharm AG Major Business
Table 79. R-Biopharm AG Fecal Immunochemical Diagnostic Tests Product and Services
Table 80. R-Biopharm AG Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. R-Biopharm AG Recent Developments/Updates
Table 82. R-Biopharm AG Competitive Strengths & Weaknesses
Table 83. Polymedco Basic Information, Manufacturing Base and Competitors
Table 84. Polymedco Major Business
Table 85. Polymedco Fecal Immunochemical Diagnostic Tests Product and Services
Table 86. Polymedco Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Polymedco Recent Developments/Updates
Table 88. Polymedco Competitive Strengths & Weaknesses
Table 89. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 90. Thermo Fisher Scientific Major Business
Table 91. Thermo Fisher Scientific Fecal Immunochemical Diagnostic Tests Product and Services
Table 92. Thermo Fisher Scientific Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Thermo Fisher Scientific Recent Developments/Updates
Table 94. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 95. BioMerieux Basic Information, Manufacturing Base and Competitors
Table 96. BioMerieux Major Business
Table 97. BioMerieux Fecal Immunochemical Diagnostic Tests Product and Services
Table 98. BioMerieux Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. BioMerieux Recent Developments/Updates
Table 100. BioMerieux Competitive Strengths & Weaknesses
Table 101. BTNX Basic Information, Manufacturing Base and Competitors
Table 102. BTNX Major Business
Table 103. BTNX Fecal Immunochemical Diagnostic Tests Product and Services
Table 104. BTNX Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. BTNX Recent Developments/Updates
Table 106. BTNX Competitive Strengths & Weaknesses
Table 107. Hemosure Basic Information, Manufacturing Base and Competitors
Table 108. Hemosure Major Business
Table 109. Hemosure Fecal Immunochemical Diagnostic Tests Product and Services
Table 110. Hemosure Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Hemosure Recent Developments/Updates
Table 112. Hemosure Competitive Strengths & Weaknesses
Table 113. Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table 114. Beckman Coulter Major Business
Table 115. Beckman Coulter Fecal Immunochemical Diagnostic Tests Product and Services
Table 116. Beckman Coulter Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Beckman Coulter Recent Developments/Updates
Table 118. Beckman Coulter Competitive Strengths & Weaknesses
Table 119. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 120. Abbott Laboratories Major Business
Table 121. Abbott Laboratories Fecal Immunochemical Diagnostic Tests Product and Services
Table 122. Abbott Laboratories Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Abbott Laboratories Recent Developments/Updates
Table 124. Abbott Laboratories Competitive Strengths & Weaknesses
Table 125. QuidelOrtho Corporation Basic Information, Manufacturing Base and Competitors
Table 126. QuidelOrtho Corporation Major Business
Table 127. QuidelOrtho Corporation Fecal Immunochemical Diagnostic Tests Product and Services
Table 128. QuidelOrtho Corporation Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. QuidelOrtho Corporation Recent Developments/Updates
Table 130. QuidelOrtho Corporation Competitive Strengths & Weaknesses
Table 131. Roche Diagnostics Basic Information, Manufacturing Base and Competitors
Table 132. Roche Diagnostics Major Business
Table 133. Roche Diagnostics Fecal Immunochemical Diagnostic Tests Product and Services
Table 134. Roche Diagnostics Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Roche Diagnostics Recent Developments/Updates
Table 136. Roche Diagnostics Competitive Strengths & Weaknesses
Table 137. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 138. Siemens Healthineers Major Business
Table 139. Siemens Healthineers Fecal Immunochemical Diagnostic Tests Product and Services
Table 140. Siemens Healthineers Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Siemens Healthineers Recent Developments/Updates
Table 142. Siemens Healthineers Competitive Strengths & Weaknesses
Table 143. Innovita?Biological?Technology Basic Information, Manufacturing Base and Competitors
Table 144. Innovita?Biological?Technology Major Business
Table 145. Innovita?Biological?Technology Fecal Immunochemical Diagnostic Tests Product and Services
Table 146. Innovita?Biological?Technology Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Innovita?Biological?Technology Recent Developments/Updates
Table 148. Innovita?Biological?Technology Competitive Strengths & Weaknesses
Table 149. Ave?Science & Technology Basic Information, Manufacturing Base and Competitors
Table 150. Ave?Science & Technology Major Business
Table 151. Ave?Science & Technology Fecal Immunochemical Diagnostic Tests Product and Services
Table 152. Ave?Science & Technology Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Ave?Science & Technology Recent Developments/Updates
Table 154. Ave?Science & Technology Competitive Strengths & Weaknesses
Table 155. Guangzhou Wondfo Biotech Basic Information, Manufacturing Base and Competitors
Table 156. Guangzhou Wondfo Biotech Major Business
Table 157. Guangzhou Wondfo Biotech Fecal Immunochemical Diagnostic Tests Product and Services
Table 158. Guangzhou Wondfo Biotech Fecal Immunochemical Diagnostic Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Guangzhou Wondfo Biotech Recent Developments/Updates
Table 160. Guangzhou Wondfo Biotech Competitive Strengths & Weaknesses
Table 161. Global Key Players of Fecal Immunochemical Diagnostic Tests Upstream (Raw Materials)
Table 162. Global Fecal Immunochemical Diagnostic Tests Typical Customers
LIST OF FIGURES
Figure 1. Fecal Immunochemical Diagnostic Tests Picture
Figure 2. World Fecal Immunochemical Diagnostic Tests Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Fecal Immunochemical Diagnostic Tests Total Revenue (2021-2032) & (USD Million)
Figure 4. World Fecal Immunochemical Diagnostic Tests Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Fecal Immunochemical Diagnostic Tests Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032) & (USD Million)
Figure 13. Fecal Immunochemical Diagnostic Tests Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032) & (USD Million)
Figure 16. World Fecal Immunochemical Diagnostic Tests Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032) & (USD Million)
Figure 18. China Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032) & (USD Million)
Figure 23. India Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Fecal Immunochemical Diagnostic Tests by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Fecal Immunochemical Diagnostic Tests Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Fecal Immunochemical Diagnostic Tests Markets in 2025
Figure 27. United States VS China: Fecal Immunochemical Diagnostic Tests Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Fecal Immunochemical Diagnostic Tests Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Fecal Immunochemical Diagnostic Tests Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Type in 2025
Figure 31. High Sensitivity:>90%
Figure 32. Moderate Sensitivity: 70% -90%
Figure 33. Lower Sensitivity:<70%
Figure 34. World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Type (2021-2032)
Figure 35. World Fecal Immunochemical Diagnostic Tests Market Size by Data Parameters, (USD Million), 2021 & 2025 & 2032
Figure 36. World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Data Parameters in 2025
Figure 37. Qualitative Test
Figure 38. Quantitative Test
Figure 39. World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Data Parameters (2021-2032)
Figure 40. World Fecal Immunochemical Diagnostic Tests Market Size by Technology Platform, (USD Million), 2021 & 2025 & 2032
Figure 41. World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Technology Platform in 2025
Figure 42. Immunoturbidimetry
Figure 43. Immunochromatography
Figure 44. World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Technology Platform (2021-2032)
Figure 45. World Fecal Immunochemical Diagnostic Tests Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 46. World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Application in 2025
Figure 47. Cancer Centers
Figure 48. Nursing Homes
Figure 49. Hospitals
Figure 50. Homecare Settings
Figure 51. World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Application (2021-2032)
Figure 52. Fecal Immunochemical Diagnostic Tests Industrial Chain
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Fecal Immunochemical Diagnostic Tests Picture
Figure 2. World Fecal Immunochemical Diagnostic Tests Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Fecal Immunochemical Diagnostic Tests Total Revenue (2021-2032) & (USD Million)
Figure 4. World Fecal Immunochemical Diagnostic Tests Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Fecal Immunochemical Diagnostic Tests Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Fecal Immunochemical Diagnostic Tests Revenue (2021-2032) & (USD Million)
Figure 13. Fecal Immunochemical Diagnostic Tests Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032) & (USD Million)
Figure 16. World Fecal Immunochemical Diagnostic Tests Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032) & (USD Million)
Figure 18. China Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032) & (USD Million)
Figure 23. India Fecal Immunochemical Diagnostic Tests Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Fecal Immunochemical Diagnostic Tests by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Fecal Immunochemical Diagnostic Tests Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Fecal Immunochemical Diagnostic Tests Markets in 2025
Figure 27. United States VS China: Fecal Immunochemical Diagnostic Tests Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Fecal Immunochemical Diagnostic Tests Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Fecal Immunochemical Diagnostic Tests Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Type in 2025
Figure 31. High Sensitivity:>90%
Figure 32. Moderate Sensitivity: 70% -90%
Figure 33. Lower Sensitivity:<70%
Figure 34. World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Type (2021-2032)
Figure 35. World Fecal Immunochemical Diagnostic Tests Market Size by Data Parameters, (USD Million), 2021 & 2025 & 2032
Figure 36. World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Data Parameters in 2025
Figure 37. Qualitative Test
Figure 38. Quantitative Test
Figure 39. World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Data Parameters (2021-2032)
Figure 40. World Fecal Immunochemical Diagnostic Tests Market Size by Technology Platform, (USD Million), 2021 & 2025 & 2032
Figure 41. World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Technology Platform in 2025
Figure 42. Immunoturbidimetry
Figure 43. Immunochromatography
Figure 44. World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Technology Platform (2021-2032)
Figure 45. World Fecal Immunochemical Diagnostic Tests Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 46. World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Application in 2025
Figure 47. Cancer Centers
Figure 48. Nursing Homes
Figure 49. Hospitals
Figure 50. Homecare Settings
Figure 51. World Fecal Immunochemical Diagnostic Tests Market Size Market Share by Application (2021-2032)
Figure 52. Fecal Immunochemical Diagnostic Tests Industrial Chain
Figure 53. Methodology
Figure 54. Research Process and Data Source
